Skip to main content

and
  1. Article

    Open Access

    ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype

    Neuroendocrine phenotype is commonly associated with therapy resistance and poor prognoses in small-cell neuroendocrine cancers (SCNCs), such as neuroendocrine prostate cancer (NEPC) and small-cell lung cancer...

    Michelle Shen, Shiqin Liu, Angus Toland, En-Chi Hsu in British Journal of Cancer (2023)

  2. No Access

    Article

    A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis

    Checkpoint inhibitors produce durable responses in numerous metastatic cancers, but immune-related adverse events (irAEs) complicate and limit their benefit. IrAEs can affect organ systems idiosyncratically; p...

    Douglas B. Johnson, Wyatt J. McDonnell, Paula I. Gonzalez-Ericsson in Nature Medicine (2019)

  3. No Access

    Article

    A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors

    We introduce and validate a new precision oncology framework for the systematic prioritization of drugs targeting mechanistic tumor dependencies in individual patients. Compounds are prioritized on the basis o...

    Mariano J. Alvarez, Prem S. Subramaniam, Laura H. Tang, Adina Grunn in Nature Genetics (2018)

  4. No Access

    Protocol

    Patch-Clamp Recording Methods for Examining Adrenergic Regulation of Potassium Currents in Ocular Epithelial Cells

    Neurotransmitters act on cell-surface receptors to produce a wide range of effects on target cells (1). These effects include modulation of ion channels and changes in cellular electrical properties. Deciphering ...

    Jennifer S. Ryan, Chanjuan Shi, Melanie E. M. Kelly in Adrenergic Receptor Protocols (2000)